We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · June 09, 2016

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

The New England Journal of Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

The New England Journal of Medicine
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
N. Engl. J. Med 2016 Jun 05;[EPub Ahead of Print], PE Goss, JN Ingle, KI Pritchard, NJ Robert, H Muss, J Gralow, K Gelmon, T Whelan, K Strasser-Weippl, S Rubin, K Sturtz, AC Wolff, E Winer, C Hudis, A Stopeck, JT Beck, JS Kaur, K Whelan, D Tu, WR Parulekar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading